Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
What’s Your Call?
Collective community sentiment on Denis Chem Lab Ltd
Your Vote -
Buy
50.00%
Hold
0.00%
Sell
50.00%
50.00%
2 users have voted
Option Chain
Analyzes market sentiment, predicts Denis Chem Lab Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Denis Chem Lab L - Integrated Filing (Financial)
-
Denis Chem Lab L Q3 net profit down 45.00% at Rs 1.76 cr
-
Denis Chem Lab L - Results-Financial Results For The Quarter Ended On December 31, 2024
-
Denis Chem Lab L - Board Meeting Outcome for Outcome Of Board Meeting - Submission Of Unaudited Financial Results For The Qua
-
Denis Chem Lab L - Disclosure On Imposition Of Penalty
-
Denis Chem Lab L - Board Meeting Intimation for Taking On Record Unaudited Financial Results\r\nFor The Quarter Ended On 31St
-
Denis Chem Lab L - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Denis Chem Lab L - Intimation Regarding Change Of Name Of Registrar And Share Transfer Agent ('RTA') Of The Company
Key fundamentals
Evaluate the intrinsic value of Denis Chem Lab Ltd stock
| Name | March-24 | March-23 | March-22 | March-21 | March-20 |
|---|---|---|---|---|---|
| Assets | 81.4125 | 74.1967 | 69.6689 | 70.6503 | 69.5968 |
| Liabilities | 81.4125 | 74.1967 | 69.6689 | 70.6503 | 69.5968 |
| Equity | 13.8767 | 13.8767 | 13.8767 | 13.8766 | 13.8766 |
| Gross Profit | 21.2332 | 18.7799 | 14.3514 | 10.2532 | 15.0003 |
| Net Profit | 11.1558 | 7.8598 | 6.263 | 2.2644 | 4.214 |
| Cash From Operating Activities | 17.6035 | 16.3396 | 17.0703 | 7.9675 | 13.3746 |
| NPM(%) | 6.64 | 4.88 | 4.58 | 2.07 | 3.09 |
| Revenue | 167.822 | 160.8489 | 136.5565 | 109.3165 | 136.1456 |
| Expenses | 146.5888 | 142.069 | 122.2051 | 99.0632 | 121.1453 |
| ROE(%) | 13.52 | 9.53 | 7.59 | 2.74 | 5.11 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Denis Chem Lab Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 809.25 | -0.64 | 11.41 | 52.02 | 1321.50 | 1.42 |
| Lotus Eye Hospital and Institute Ltd | 58.19 | 1.50 | 237.75 | 189.56 | 14.01 | 0.88 |
| Bharat Immunological and Biologicals Corporation Ltd | 21.32 | -1.30 | 0.00 | 393.59 | -39.50 | 0.00 |
| Astec Lifesciences Ltd | 654.90 | -5.39 | 0.00 | 178.74 | -239.30 | 0.00 |
Company Info
The Company is Public Limited Pharmaceutical Company incorporated in 1982. Company started commercial production for sterile Intravenous injectibles in 1984. Since more than 30 years Company have been actively delivering high quality sterile Intravenous injectibles and contributing in saving lives. Company Manufacture and market sterile Intravenous injectibles in Both Glass and Plastic Bottles with capacity of 810 million bottles per Annum. 1980 -Incorporated as a Private Limited Company on July 15, 1980 1982 -Conversion into Public Limited Company -Initial Public Offer of our Company 1984 -Rights Issue of 70,000 equity shares at a issue price of ` 10/- per share 1989 -Rights Issue of 1,17,728 equity shares at a issue price of ` 10/- per share 1991 -Production capacity increased to 8 million glass bottles per annum 1994 -Production capacity again increased to 20 million glass bottles for I.V. Fluids 1995 -Further Public Offer of 1,80,750 equity shares 2006 -Company forayed into manufacturing of IV fluids in PP bottles using BFS technology 2013 -Issue of Bonus Shares in the ratio of 1:1 2014 -Listing of Equity Shares of our Company on BSE Limited under the Direct Listing Norms -Sucessfuly Launched Aqua Pulse Pan India -Company has issues Rights in the Ratio of 2 : 1
The Company is Public Limited Pharmaceutical Company incorporated in 1982. Company started commercial production for sterile Intravenous injectibles in 1984. Since more than 30 years Company have been actively delivering high quality sterile Intravenous injectibles and contributing in saving lives. Company Manufacture and market sterile Intravenous injectibles in Both Glass and Plastic Bottles with capacity of 810 million bottles per Annum. 1980 -Incorporated as a Private Limited Company on July 15, 1980 1982 -Conversion into Public Limited Company -Initial Public Offer of our Company 1984 -Rights Issue of 70,000 equity shares at a issue price of ` 10/- per share 1989 -Rights Issue of 1,17,728 equity shares at a issue price of ` 10/- per share 1991 -Production capacity increased to 8 million glass bottles per annum 1994 -Production capacity again increased to 20 million glass bottles for I.V. Fluids 1995 -Further Public Offer of 1,80,750 equity shares 2006 -Company forayed into manufacturing of IV fluids in PP bottles using BFS technology 2013 -Issue of Bonus Shares in the ratio of 1:1 2014 -Listing of Equity Shares of our Company on BSE Limited under the Direct Listing Norms -Sucessfuly Launched Aqua Pulse Pan India -Company has issues Rights in the Ratio of 2 : 1
Read More
Parent Organisation
Denis Chem Lab Ltd.
Founded
15/07/1980
Managing Director
Dr.Himanshu C Patel
NSE Symbol
FAQ
The current price of Denis Chem Lab Ltd is
The 52-week high for Denis Chem Lab Ltd is
The market capitalization of Denis Chem Lab Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Denis Chem Lab Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Denis Chem Lab Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Denis Chem Lab Ltd shares.
The CEO of Denis Chem Lab Ltd is Dr.Himanshu C Patel, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
